Filed before 2025Filed 10 October 2019
Variant Bio, Inc. raised $16.6M
Variant Bio, Inc., a biotech company based in New York, NY, raised $16.6M in a new equity round, according to a filing dated 10 October 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 10 October 2019
- Round
- Equity round
- Amount sold
- $16.6M
- Offering size
- $31.5M
- Investors so far
- 2
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 72% of the 1,781 tracked raises with an amount filed in 2019, and than 62% of the 146 in biotech.
Variant Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Nov 2021 | Amended filing | $105M | Another raise |
| 4 Nov 2021 | New filing | $95M | Another raise |
| 5 Aug 2020 | New filing | $6.1M | Another raise |
| 10 Oct 2019 | New filing | $16.6M | This raise |
More with Dimension Capital on the board
- Odyssey Therapeutics, Inc.$214M
- Fiveonefour Labs Inc.$10.8M
- NewLimit, Inc.$130M
- Enveda Therapeutics, Inc.$62.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.